Navigation Links
Integral Vision, Inc. Announces SharpEye(TM) Order From New Customer

WIXOM, Mich., Jan. 14 /PRNewswire-FirstCall/ -- Integral Vision, Inc. (OTC Bulletin Board: INVI), a leading global supplier of automated display inspection technology, today announced it has received an order for the Company's SharpEye(TM) system from a new customer. This customer is a large computer manufacturer. The SharpEye product provides analysis of functional and cosmetic defects in the display to assure quality in the manufacturing process, and the system will be used by the customer to inspect defects in LCD displays of various sizes.

"We are very pleased to receive this order. The SharpEye system will be used to establish acceptance criterion for various LCD defects. The resulting defect limits will be required to be adopted by all of the LCD suppliers to this company. We expect these specifications to generate system sales for Integral Vision from all of the LCD panel suppliers of this new customer," said Charles J. Drake, chairman and CEO of Integral Vision, Inc.

About Integral Vision

Integral Vision, Inc. (OTC Bulletin Board: INVI), an ISO 9001 registered firm, offers display inspection technology that provides analysis of functional and cosmetic defects in the display to assure quality in the manufacturing process as well as verification of the final product. Integral Vision has been inspecting displays since 1992 and is an industry leader committed to providing automated solutions to the quality issues Microdisplay, OLED and LCD manufacturers face in today's competitive marketplace. A transcript of an interview by our CEO, which gives an overview of the Company, can be found at More information can be found at Website:

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Such statements are based on management's current expectations and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such factors and uncertainties include, but are not limited to: competitive conditions in the Company's markets and the effect of competitive products and pricing; technological development by the Company, its customers and its competition; the Company's available cash and access to debt and equity financing; and general economic conditions and conditions in the specific industries in which the company has significant customers. As a result, the Company's results may fluctuate. Additional information concerning risk factors that could cause actual results to differ materially from those projected in the forward-looking statements are contained in the Company's filings with the Securities and Exchange Commission. These forward-looking statements represent the Company's best estimates as of the date of this press release. The Company assumes no obligation to update such estimates except as required by the rules and regulations of the Securities and Exchange Commission.

SOURCE Integral Vision, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology news :

1. Corporate Safe Specialists Announces Addition to Sales Team
2. e-Smart(R) Technologies, Inc., Announces Next Generation Superthin Polyimide Flexible Circuit Biometric Super Smart Card(TM) card, the i am(TM) Card.
3. Accu-Time Systems, Inc. Announces Launch of Next Generation Human Capital Management (HCM) solutions: Global Series(TM)
4. Oncolytics Biotech, Inc. announces publication of research
5. Experimental Biology and Medicine announces expansion into Asia, opens new office
6. Biophysical Society announces winners of 2008 Minority Travel Awards
7. Biophysical Society announces winners of 2008 Student Travel Awards
8. Biophysical Society announces 2008 International Travel Awards
9. bioMETRX, Inc. Announces Integration of AuthenTec Fingerprint Sensor in smartTOUCH(TM) Product Line
10. Titanium Group Announces Launch of New Identification Solution Targeting High Growth Retail Sector
11. Aware, Inc. Announces Richard Moberg to Return as CFO
Post Your Comments:
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" ... by its major shareholders, Clean Technology Fund I, LP ... States based venture capital funds which together ... (on a fully diluted, as converted basis), that they ... their entire equity holdings in Biorem to TUS Holdings ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
Breaking Biology Technology: